Stockreport

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit [Yahoo! Finance]

Protagenic Therapeutics, Inc.  (PTIX) 
US:NASDAQ Investor Relations: protagenic.com/investors
PDF NEW YORK, NY / ACCESSWIRE / April 17, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a pioneer in biopharmaceutical research, announced today that Dr. Andrew Slee, [Read more]